CRIS Current Research Information System

MANFREDI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.808
NA - Nord America 16.781
AS - Asia 14.149
SA - Sud America 1.232
AF - Africa 862
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 5
Totale 49.853
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.691
GB - Regno Unito 5.465
CN - Cina 4.609
SG - Singapore 4.282
UA - Ucraina 2.292
IT - Italia 2.286
DE - Germania 2.255
VN - Vietnam 2.236
SE - Svezia 1.297
HK - Hong Kong 1.037
RU - Federazione Russa 1.019
IN - India 932
BR - Brasile 897
FR - Francia 769
IE - Irlanda 517
JP - Giappone 444
ZA - Sudafrica 345
EE - Estonia 337
KR - Corea 289
SC - Seychelles 209
NL - Olanda 203
AR - Argentina 154
CI - Costa d'Avorio 133
TG - Togo 98
ID - Indonesia 76
FI - Finlandia 60
EC - Ecuador 53
CH - Svizzera 47
GR - Grecia 45
BG - Bulgaria 41
MX - Messico 39
LB - Libano 35
CA - Canada 34
CO - Colombia 34
AT - Austria 31
PY - Paraguay 29
PL - Polonia 27
BD - Bangladesh 25
CL - Cile 25
JO - Giordania 25
TR - Turchia 24
IQ - Iraq 21
MY - Malesia 20
BE - Belgio 19
MA - Marocco 18
VE - Venezuela 17
ES - Italia 16
UZ - Uzbekistan 16
IR - Iran 15
AU - Australia 14
CZ - Repubblica Ceca 14
KE - Kenya 13
PE - Perù 12
RO - Romania 12
EG - Egitto 10
LT - Lituania 10
NG - Nigeria 9
PH - Filippine 8
TH - Thailandia 8
TN - Tunisia 7
DO - Repubblica Dominicana 6
SA - Arabia Saudita 6
SI - Slovenia 6
SK - Slovacchia (Repubblica Slovacca) 6
UY - Uruguay 6
AL - Albania 5
HU - Ungheria 5
KZ - Kazakistan 5
NP - Nepal 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
DK - Danimarca 4
EU - Europa 4
IL - Israele 4
PK - Pakistan 4
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
PA - Panama 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CG - Congo 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
LK - Sri Lanka 2
LU - Lussemburgo 2
PS - Palestinian Territory 2
TL - Timor Orientale 2
ZW - Zimbabwe 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
CM - Camerun 1
GA - Gabon 1
GE - Georgia 1
Totale 49.828
Salva come PNG Salva come JPEG
Città #
Southend 4.922
Singapore 2.631
Jacksonville 1.672
Fairfield 1.530
Ashburn 1.319
Hefei 1.040
Hong Kong 1.034
Chandler 1.008
Wilmington 941
Princeton 936
Dong Ket 901
Santa Clara 771
Woodbridge 752
Seattle 645
Houston 637
Boardman 544
Cambridge 539
Dublin 511
Nanjing 468
Ann Arbor 455
Westminster 454
Padova 449
Tokyo 435
Beijing 368
Bologna 364
Berlin 338
Seoul 287
Los Angeles 271
Ho Chi Minh City 258
Mülheim 255
Milan 249
Saint Petersburg 222
Jinan 212
Buffalo 207
Dallas 206
Mahé 196
Shenyang 192
Medford 190
Hanoi 175
Hebei 148
Nanchang 139
Abidjan 133
Changsha 127
San Diego 123
Verona 113
Tianjin 106
Redondo Beach 100
Lomé 98
Des Moines 90
Jiaxing 84
Rome 78
São Paulo 72
Zhengzhou 72
Hangzhou 71
Dearborn 69
Kunming 66
Yubileyny 66
Bengaluru 61
Guangzhou 61
Shanghai 61
Redmond 59
Norwalk 58
The Dalles 58
Olalla 57
Ningbo 54
Falls Church 52
Helsinki 46
Lanzhou 46
Haikou 45
Chicago 42
New York 42
Ingolstadt 39
Rio de Janeiro 38
Phoenix 37
Sofia 36
Bühl 35
Redwood City 35
Taizhou 34
Frankfurt am Main 33
Turin 32
Haiphong 30
London 26
Taiyuan 26
Wuhan 26
Amman 25
Florence 24
Jakarta 24
Xi'an 23
Moscow 22
Bern 21
Biên Hòa 21
Da Nang 21
Qingdao 21
Council Bluffs 20
Fuzhou 20
Quito 20
Shenzhen 20
Foshan 19
Guayaquil 19
Hải Dương 19
Totale 31.847
Salva come PNG Salva come JPEG
Nome #
Update on the appropriate use of linezolid in clinical practice 563
Candidosi esofagea ricorrente in corso di infezione da HIV non associata ad evidente stato di immunodeficienza, ed in presenza di un trattamento antiretrovirale efficace 256
Acute onset myopericarditis as unusual presentation of primary HIV infection 220
Turicella otitidis central venous-related bacteremia during pediatric acute lymphoblastic leukemia 208
Assessing the impact of hepatitis C virus coinfection on lopinavir/ritonavir trough concentrations in HIV-infected patients. 203
The destiny of italian prisoners in austro-hungarian pow camps during the first world war: Remembering the defeat of caporetto 100 years on 201
Ultrastructural liver mitochondrial abnormalities in HIV/HCV-coinfected patients receiving antiretroviral therapy 194
A decade surveillance study of Mycobacterium xenopi disease and antimicrobial susceptibility levels in a reference teaching hospital of northern Italy: HIV-associated versus non-HIV-associated infection. 194
A 2-year survey of bacteriologic profile and antimicrobial susceptibility levels of Enterococci in a large Italian teaching hospital. 193
Admission of foreign citizens to the general teaching hospital of Bologna, northeastern Italy: an epidemiological and clinical survey 193
HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report 185
Cardiovascular risk factors and ultrasound evaluation of carotid atherosclerosis in patients with HIV-1 infection. 180
Substitution of nevirapine or efavirenz for protease inhibitor versus lipid-lowering therapy for the management of dyslipidaemia. 179
Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis 177
A novel antiretroviral class (fusion inhibitors) in the management of HIV infection. Present features and future perspectives of enfuvirtide (T-20) 175
Fatal long-term immunosuppressive therapy with uncontrolled repeat prescription 174
Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis, and clinical management 173
Causes of hospitalization among Extra-European Union children in a large Hospital of Northern Italy, in a five-year observation period 170
Abacavir-induced febrile agranulocytosis and anaemia. 168
Atypical progressive multifocal leukoencephalopathy in HIV with a high CD4 count: the use of magnetic resonance imaging plus spectrometry studies 168
A prospective evaluation of maraviroc administration in patients with advanced HIV disease and multiple comorbidities: focus on efficacy and tolerability issues 168
Prevalence of renal disease within an urban HIV-infected cohort in northern Italy. 163
Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management 161
Dual raltegravir-darunavir/ritonavir combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy including a ritonavir-boosted protease inhibitor plus two nucleoside/nucleotide reverse transcriptase inhibitors 161
Insulin resistance and diabetes mellitus in HIV-infected patients receiving antiretroviral therapy 159
Diffusa disseminazione cutanea di una leishmaniosi viscerale in corso di infezione da HIV: un percorso diagnostico e terapeutico. 159
Increasing pathomorphism of pulmonary tuberculosis: an observational study of slow clinical, microbiological, and imaging response of lung tuberculosis to specific treatment. Which role for linezolid? 159
A puzzling microbiological and clinical discrepancy in the management of acute, severe skin-soft tissue and joint staphylococcal infection. In vitro antimicrobial susceptibility to glycopeptides, versus in vivo clinical efficacy of linezolid alone 158
Plasma Levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controls. 157
Chronic hepatitis with diffuse steatosis and slight fibrosis related to etretinate therapy 156
Basic clinical-applied pharmacoeconomic features of antiretroviral therapy. A pilot single-centre study performed on around 1000 HIV-infected individuals receiving combined antiretroviral treatment 156
Pancreotoxicity of propofol sedation during purulent meningitis. 155
Abdominal neoplasia with sarcomatoid features as the presenting illness of a patient with a newly diagnosed HIV infection and no AIDS-related disorders. Case report, clinical and diagnostic features, and literature discussion 155
Skeletal muscle toxicity in HIV-1-infected patients treated with a raltegravir-containing antiretroviral therapy: a cohort study. 155
Management of Strongyloides stercoralis extensive infestation in a patient with Sjogren syndrome 154
Paradoxical response to intravenous immunoglobulin in a case of Parvovirus B19-associated chronic fatigue syndrome 154
A very particular case of long-term non-progressor: nineteen consecutive years of follow-up in the absence of any detectable HIV-1 viraemia 153
Gynecomastia, lipodystrophy syndrome, and dyslipidemia occurring or worsening during antiretroviral regimens other than protease inhibitor-based ones. 151
Long-term "self-managed" immunosuppressive treatment resulting in death due to fulminant hepatitis B 151
Protease inhibitor monotherapy as maintenance regimen in patients with HIV infection. 151
Bone mass loss in patients with human immunodeficiency virus type 1 infection: association with male sex and protease inhibitor therapy 150
Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study. 149
A prospective comparison of hepatotoxicity of the two currently available non-nucleoside reverse transcriptase inhibitors in a homogeneous case-mix of HIV-infected patients treated for the first time with efavirenz or nevirapine, according to their different baseline conditions 149
Candida albicans panuveitis and an uneven therapeutic ground, passing through all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole 149
No correlation between statin exposure and incident diabetes mellitus in HIV-1-infected patients receiving combination antiretroviral therapy 149
Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapine 147
Liposomal amphotericin B and HIV-associated visceral leishmaniasis: concerns about nephrotoxicity and administration schedule 147
Severe peripheral neuropathy with areflexic and flaccid quadriplegia complicating Legionnaires’ disease in an adult patient. 147
Antibodies reactive with C-terminus of the second conserved region of HIV-1 gp120 as possible prognostic marker and therapeutic agent for HIV disease 146
Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy 144
Neurosyphilis in a young adult: very early tertiary syphilis? 143
Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir 143
Membranoproliferative glomerulonephritis associated with human immunodeficiency virus, hepatitis B and hepatitis C virus coinfection: case report and literature review. 142
Methicillin-resistant staphylococci still susceptible to non-beta-lactam antibiotics. What clinical implications in nosocomially-acquired infections? 142
Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients. 142
La peste di Giustiniano (prima parte) 142
Polyunsaturated ethyl esters on n-3 fatty acids in HIV-infected patients with moderate hypertriglyceridemia: comparison with dietary and lifestyle changes, and fibrate therapy. 141
Efavirenz versus nevirapine in current clinical practice: a prospective, open-label observational study. 141
First-line efavirenz versus lopinavir/ritonavir-based highly active antiretroviral therapy for naïve patients. 141
Legionnaires' disease associated with macular rash: two cases 141
Abacavir-lamivudina versus tenofovir-emtricitabina più atazanavir-ritonavir nella semplificazione dell'HAART per dislipidemia 141
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitors: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/mmc) 140
Measles outbreak in the city of Bologna, December 2007 to May 2008 140
Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients. 140
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure 140
Two-Year Treatment with Rosuvastatin Reduces Carotid Intima-Media Thickness in HIV Type 1-Infected Patients Receiving Highly Active Antiretroviral Therapy with Asymptomatic Atherosclerosis and Moderate Cardiovascular Risk. 139
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS 139
Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy. 138
Changing epidemiology of hepatitis A in the Bologna metropolitan area, northern Italy: importance of counselling and prophylactic measures for the male homo/bisexual population. 138
Aggressive, metastatic squamous cell carcinoma after a 46-year-old history of chronic osteomyelitis and local infectious complications: a case report 138
Primary Cytomegalovirus infection in otherwise healthy adults with Fever of Unknown Origin: a 3-year prospective survey 137
Aderenza alla terapia antiretrovirale "autogestita" dai pazienti alla metà della posologia giornaliera raccomandata. Inattesa efficacia immunologica e virologica a lungo termine 137
An observational study of subcutaneous multiple lipomatosis in patients receiving highly active antiretroviral therapy. Possible correlations with metabolic abnormalities and pathogenetic insights 136
Cytokine storm in aged people with CoV-2: possible role of vitamins as therapy or preventive strategy 136
The plague which hit the city of Bologna in the year 1630 136
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV-infected patients treated with ritonavir-boosted protease inhibitors. 135
Epidemiological, clinical and therapeutic features of AIDS-related Mycobacterium kansasii infection during the HIV pandemic: an 11-year follow-up study. 135
Georges Canguilhem. Sulla Medicina. Scritti 1955-1989, Einaudi, 2007 134
Advanced acute myelogenous leukaemia (AML) during HAART-treated HIV disease, manifesting initially as a thyroid mass 134
Tuberculosis in a metropolitan area of northern Italy: epidemiological trends and public health concerns 133
Novel pharmaceutical molecules against emerging resistant gram-positive cocci 133
Bladder carcinoma and HIV infection during the highly active antiretroviral therapy era: a rare, but intriguing association. Two case reports and literature review 133
An extremely different dysmetabolic profile between the two available nonucleoside reverse transcriptase inhibitors: efavirenz and nevirapine. 132
Loss of bone mass in chronically HIV-infected patients. Significant association with male gender and protease inhibitor administration 132
Efficacy and tolerability of a fosamprenavir-ritonavir-based versus a lopinavir-ritonavir-based antiretroviral treatment in 82 therapy-naïve patients with HIV-1 infection. 132
A patient with a 12-year history characterized by four non-AIDS-related malignancies, occurring before and after the disclosure of HIV infection 132
Safety issues about nevirapine administration in HIV-infected pregnant women 131
A woman with multiple autoimmune diseases: pathologic correlations and complications 131
Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration 131
Community-acquired pneumonia and sepsis caused by a multiresistant Staphylococcus aureus strain resulting in a severe and long-lasting multiple organ inflammatory involvement 131
Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy. 131
Reversal of major genotypic tipranavir mutations under long-term treatment with tipranavir/ritonavir itself with very limited optimized background, during deep salvage antiretroviral therapy 130
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors 130
Severe Community - Acquired Achromobacter denitrificans Cellulitis 129
AIDS: esiste ancora? Storia e Prevenzione 129
In vitro antimicrobial sensitivity trends of Enterococci isolated at an Italian teaching hospital. A 2004-2007 prospective report including over 2,700 examined microbial strains 129
Lowering HIV fitness and replication rate by administration of lamivudine alone, in extensively resistant HIV-infected patients, as a "bridging" strategy towards optimized salvage regimens 129
Hyperacute fulminant fungal peritonitis and ascites in a HIV-infected patient with HCV-related, compensated liver cirrhosis. A supportive role for prolonged nimesulide self-administration? 128
Serious, multi-organ hypersensitivity to lopinavir alone, involving cutaneous-mucous rash, and myeloid, liver, and kidney function 128
Tubercular disease caused by Bacillus of Calmette-Guérin as a local adjuvant treatment of relapsing bladder carcinoma 128
Totale 15.560
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.246
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.577 0 0 0 0 0 371 87 406 311 422 354 1.626
2021/20226.973 780 380 439 685 645 477 116 468 216 347 1.170 1.250
2022/20235.626 735 882 352 681 343 328 191 269 937 160 580 168
2023/20241.201 100 241 101 101 87 159 82 71 43 111 51 54
2024/20257.001 155 1.576 763 521 1.444 314 394 105 79 253 96 1.301
2025/20268.781 815 1.663 2.162 1.606 1.936 599 0 0 0 0 0 0
Totale 50.424